ELDN — ELEDON PHARMACEUTICALS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 169 家机构在其最新 13F 申报中持有 ELDN(ELEDON PHARMACEUTICALS INC),合计申报市值 $190.54M,对应 48.59M 股。按股数计算较上季度增持 9.2%(+3.61M 股),申报市值环比上升 39.2%。持仓集中度较高:前五大持有人占申报市值的 43.2%,前十大的集中度为 62.4%。
与上一季度相比,54 家新建仓位、65 家加仓、24 家减仓、12 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
ELEDON PHARMACEUTICALS INC(ELDN)的主要机构持有人包括 BVF INC/IL、BlackRock Inc、Defilade Capital Management, L.P.,按 13F 申报市值在本页 258 家持有人中排名居前。
ELDN 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 115 | 23.84M | $59.92M | +6.2% |
| Q2 2026 | 169 | 48.59M | $190.54M | +9.2% |
| Q1 2026 | 127 | 43.11M | $132.60M | -1.8% |
| Q4 2025 | 102 | 44.47M | $67.13M | +28.3% |
| Q3 2025 | 86 | 36.72M | $95.81M | +5.1% |
| Q2 2025 | 87 | 38.27M | $104.46M | -1.1% |
| Q1 2025 | 81 | 39.29M | $133.34M | +5.0% |
| Q4 2024 | 73 | 38.41M | $158.69M | +37.8% |
表内 8 个季度中,机构持股合计减少 38%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2024(+37.8%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.64M | $16.80M | 0.00% | 增持 | |
| 3.42M | $8.65M | 0.00% | 持有 | |
| 1.98M | $5.01M | 0.00% | 增持 | |
| 1.76M | $4.44M | 0.01% | 减持 | |
| 1.61M | $4.09M | 0.00% | 增持 | |
| 1.10M | $2.78M | 0.27% | 持有 | |
| 636.36K | $1.61M | 1.12% | 持有 | |
| 575.67K | $1.46M | 0.00% | 增持 | |
| 556.90K | $1.41M | 0.00% | 增持 | |
| 542.68K | $1.37M | 0.00% | 增持 | |
| 532.69K | $1.35M | 0.00% | 减持 | |
| 525.00K | $1.33M | 0.89% | 减持 | |
| 511.56K | $1.29M | 0.00% | 减持 | |
| 427.00K | $1.08M | 0.05% | 增持 | |
| 271.05K | $685.76K | 0.00% | 新进 | |
| 250.90K | $634.78K | 0.00% | 减持 | |
| 224.04K | $566.82K | 0.00% | 增持 | |
| 158.92K | $402.06K | 0.00% | 减持 | |
| 127.93K | $323.67K | 0.00% | 增持 | |
| 122.06K | $308.80K | 0.00% | 增持 | |
| 95.11K | $240.63K | 0.00% | 增持 | |
| 91.67K | $230.54K | 0.16% | 增持 | |
| 87.99K | $222.60K | 0.00% | 减持 | |
| 86.70K | $219.36K | 0.07% | 持有 | |
| 76.19K | $192.77K | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.29M | $24.80M | 0.63% | 持有 | |
| 5.12M | $20.19M | 0.00% | 增持 | |
| 3.53M | $13.89M | 1.86% | 减持 | |
| 3.42M | $13.46M | 0.00% | 增持 | |
| 2.51M | $9.89M | 0.00% | 增持 | |
| 2.10M | $8.28M | 0.01% | 减持 | |
| 1.96M | $7.71M | 0.00% | 新进 | |
| 1.96M | $7.71M | 0.00% | 增持 | |
| 1.70M | $6.68M | 1.25% | 增持 | |
| 1.60M | $6.29M | 0.16% | 减持 | |
| 1.19M | $4.69M | 0.66% | 减持 | |
| 1.10M | $4.33M | 0.38% | 持有 | |
| 1.05M | $4.13M | 0.00% | 增持 | |
| 1.04M | $4.09M | 0.45% | 持有 | |
| 979.71K | $3.86M | 0.00% | 新进 | |
| 979.71K | $3.86M | 0.01% | 新进 | |
| 883.10K | $3.48M | 0.00% | 增持 | |
| 647.81K | $2.55M | 0.14% | 减持 | |
| 636.36K | $2.51M | 2.40% | 持有 | |
| 616.40K | $2.43M | 0.00% | 增持 | |
| 581.03K | $2.29M | 0.00% | 增持 | |
| 581.03K | $2.29M | 0.00% | 增持 | |
| 575.00K | $2.27M | 1.44% | 减持 | |
| 538.74K | $2.12M | 0.00% | 增持 | |
| 533.37K | $2.10M | 0.00% | 增持 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.29M | $19.38M | 0.62% | 持有 | |
| 4.38M | $13.50M | 0.00% | 增持 | |
| 3.56M | $10.98M | 1.54% | 增持 | |
| 3.29M | $10.14M | 0.00% | 新进 | |
| 2.46M | $7.59M | 0.01% | 持有 | |
| 1.88M | $5.78M | 0.16% | 减持 | |
| 1.79M | $5.52M | 0.00% | 增持 | |
| 1.77M | $5.46M | 0.90% | 减持 | |
| 1.64M | $5.05M | 1.05% | 增持 | |
| 1.42M | $4.37M | 1.35% | 减持 | |
| 1.15M | $3.56M | 0.00% | 增持 | |
| 1.10M | $3.39M | 0.38% | 持有 | |
| 1.09M | $3.37M | 0.06% | 减持 | |
| 1.04M | $3.20M | 0.36% | 持有 | |
| 974.42K | $3.00M | 0.21% | 减持 | |
| 869.54K | $2.68M | 0.00% | 增持 | |
| 814.98K | $2.51M | 0.75% | 持有 | |
| 650.00K | $2.00M | 1.67% | 持有 | |
| 636.36K | $1.96M | 1.34% | 持有 | |
| 635.85K | $1.96M | 0.00% | 增持 | |
| 547.45K | $1.69M | 0.00% | 减持 | |
| 543.84K | $1.68M | 0.00% | 增持 | |
| 503.76K | $1.55M | 0.00% | 新进 | |
| 429.89K | $1.32M | 0.00% | 新进 | |
| 370.09K | $1.14M | 0.00% | 增持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.29M | $9.50M | 0.32% | 持有 | |
| 4.04M | $6.10M | 0.00% | 增持 | |
| 3.63M | $5.48M | 0.00% | 增持 | |
| 3.29M | $4.97M | 0.67% | 新进 | |
| 2.46M | $3.72M | 0.01% | 增持 | |
| 2.38M | $3.60M | 0.10% | 增持 | |
| 2.13M | $3.22M | 0.64% | 增持 | |
| 1.93M | $2.91M | 0.90% | 增持 | |
| 1.82M | $2.75M | 0.21% | 新进 | |
| 1.58M | $2.39M | 0.03% | 新进 | |
| 1.42M | $2.15M | 0.00% | 增持 | |
| 1.26M | $1.90M | 0.34% | 增持 | |
| 1.10M | $1.66M | 0.16% | 新进 | |
| 1.04M | $1.57M | 0.21% | 新进 | |
| 893.10K | $1.35M | 1.04% | 新进 | |
| 814.98K | $1.23M | 0.40% | 持有 | |
| 773.88K | $1.17M | 0.00% | 增持 | |
| 650.00K | $981.50K | 0.83% | 增持 | |
| 636.36K | $960.91K | 0.40% | 持有 | |
| 627.39K | $947.00K | 0.00% | 新进 | |
| 593.13K | $895.63K | 0.00% | 增持 | |
| 555.98K | $839.53K | 0.08% | 新进 | |
| 489.38K | $738.96K | 0.00% | 增持 | |
| 429.81K | $649.02K | 0.00% | 持有 | |
| 317.44K | $479.34K | 0.00% | 新进 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.29M | $16.30M | 0.66% | 持有 | |
| 3.57M | $9.24M | 0.11% | 持有 | |
| 3.47M | $8.97M | 0.00% | 增持 | |
| 3.27M | $8.46M | 0.00% | 减持 | |
| 2.07M | $5.37M | 0.21% | 增持 | |
| 1.82M | $4.73M | 0.14% | 增持 | |
| 1.37M | $3.55M | 0.00% | 减持 | |
| 1.28M | $3.33M | 0.00% | 新进 | |
| 1.28M | $3.33M | 0.00% | 新进 | |
| 1.26M | $3.28M | 0.01% | 持有 | |
| 1.14M | $2.96M | 0.12% | 持有 | |
| 1.06M | $2.75M | 0.51% | 新进 | |
| 979.91K | $2.54M | 0.79% | 减持 | |
| 814.98K | $2.11M | 0.81% | 持有 | |
| 800.82K | $2.07M | 0.01% | 减持 | |
| 732.98K | $1.90M | 0.01% | 新进 | |
| 655.48K | $1.70M | 0.00% | 增持 | |
| 636.36K | $1.65M | 0.78% | 持有 | |
| 600.00K | $1.55M | 1.30% | 增持 | |
| 428.56K | $1.11M | 0.00% | 减持 | |
| 349.20K | $904.43K | 0.00% | 增持 | |
| 346.97K | $898.66K | 0.84% | 增持 | |
| 239.16K | $619.42K | 0.00% | 减持 | |
| 37.01K | $526.95K | 0.06% | 持有 | |
| 200.00K | $518.00K | 0.12% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.29M | $17.05M | 0.61% | 持有 | |
| 3.57M | $9.66M | 0.16% | 持有 | |
| 3.32M | $8.99M | 0.00% | 增持 | |
| 3.25M | $8.82M | 0.00% | 增持 | |
| 2.60M | $7.05M | 0.91% | 增持 | |
| 1.67M | $4.53M | 0.02% | 持有 | |
| 1.38M | $3.75M | 0.00% | 增持 | |
| 1.33M | $3.60M | 1.16% | 减持 | |
| 1.26M | $3.43M | 0.01% | 持有 | |
| 1.14M | $3.09M | 0.14% | 持有 | |
| 1.10M | $2.98M | 0.34% | 持有 | |
| 1.00M | $2.71M | 0.88% | 减持 | |
| 998.45K | $2.71M | 0.02% | 减持 | |
| 980.68K | $2.66M | 0.09% | 增持 | |
| 933.48K | $2.53M | 0.01% | 持有 | |
| 814.98K | $2.21M | 1.26% | 持有 | |
| 690.17K | $1.87M | 0.10% | 持有 | |
| 636.36K | $1.72M | 1.09% | 持有 | |
| 605.34K | $1.64M | 0.00% | 增持 | |
| 454.08K | $1.23M | 0.00% | 增持 | |
| 375.00K | $1.02M | 0.93% | 增持 | |
| 345.63K | $936.65K | 0.00% | 增持 | |
| 338.97K | $918.62K | 0.91% | 增持 | |
| 293.56K | $795.56K | 0.03% | 减持 | |
| 190.67K | $516.72K | 0.00% | 增持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 1.96M 股 · $7.71M
- Millennium Management 979.71K 股 · $3.86M
- MILLENNIUM MANAGEMENT LLC 979.71K 股 · $3.86M
- Triumph Capital Management 303.44K 股 · $1.20M
- Sixth Street Partners Management Company, L.P. 247.40K 股 · $974.77K
- JACOBS LEVY EQUITY MANAGEMENT, INC 109.84K 股 · $432.77K
- Maven Securities LTD 100.00K 股 · $394.00K
- Prodigy Asset Management LLC 86.70K 股 · $341.61K
- Shay Capital LLC 64.00K 股 · $252.16K
- Wellington Management Group 51.01K 股 · $200.98K
- WELLINGTON MANAGEMENT GROUP LLP 51.01K 股 · $200.98K
- Mariner, LLC 50.04K 股 · $197.15K
完全清仓(较上季)
- STATE STREET CORP 卖出 1.15M 股 · $3.56M
- Jefferies Financial Group Inc. 卖出 1.09M 股 · $3.37M
- Sanofi 卖出 814.98K 股 · $2.51M
- SG Americas Securities, LLC 卖出 635.85K 股 · $1.96M
- Stonepine Capital Management, LLC 卖出 35.00K 股 · $107.80K
- MITCHELL & PAHL PRIVATE WEALTH, LLC 卖出 30.00K 股 · $92.40K
- Forum Private Client Group LLC 卖出 10.00K 股 · $30.80K
- CWM, LLC 卖出 9.94K 股 · $30.63K
- Addison Advisors LLC 卖出 1.30K 股 · $4.00K
- MAI Capital Management 卖出 133 股 · $410
- Root Financial Partners, LLC 卖出 110 股 · $339
- Sunbelt Securities, Inc. 卖出 26 股 · $80
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 6.64M | 5.12M | 4.38M | 3.63M | 3.47M | 3.25M | 652.62K | 617.62K | 215.87K | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.42M | 3.42M | 3.29M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.98M | 1.96M | 1.79M | 1.42M | 1.37M | 1.38M | 666.72K | 663.10K | 378.06K | 344.49K | 180.90K | 176.04K | 176.04K | 169.65K | 129.15K | 129.15K | 129.47K | 128.79K | 126.71K | 126.71K |
| Ensign Peak Advisors, Inc | 1.76M | 2.10M | 2.46M | 2.46M | 1.26M | 1.26M | 1.26M | 1.26M | 443.00K | 443.00K | 443.00K | 443.00K | 443.00K | — | — | — | — | — | — | — |
| STATE STREET CORP | 1.61M | — | 1.15M | 773.88K | 655.48K | 605.34K | 213.10K | 187.00K | 161.49K | 161.49K | 44.69K | 44.69K | 44.69K | — | — | — | — | — | — | — |
| AWM Investment Company, Inc. | 1.10M | 1.10M | 1.10M | 1.10M | — | 1.10M | 1.10M | 1.10M | — | — | — | — | — | — | — | — | — | — | — | — |
| 22NW, LP | 636.36K | 636.36K | 636.36K | 636.36K | 636.36K | 636.36K | 636.36K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 575.67K | 528.96K | 503.76K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 556.90K | 200.90K | 24.60K | 176.99K | 349.20K | 190.67K | 122.77K | 147.17K | 135.87K | 136.77K | 87.07K | 69.17K | 61.97K | 60.37K | 32.17K | 29.67K | 31.87K | 32.17K | 18.47K | 13.67K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 542.68K | 533.37K | 429.89K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 532.69K | 1.05M | 547.45K | 593.13K | 93.45K | 126.27K | 23.23K | 318.58K | 4 | 55.00K | 4 | 556 | — | 32 | 456 | 3.99K | 1.01K | 4.64K | — | 3.64K |
| CM Management, LLC | 525.00K | 575.00K | 650.00K | 650.00K | 600.00K | 375.00K | 275.00K | 275.00K | 275.00K | 160.00K | 160.00K | 140.00K | 234.80K | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 511.56K | 538.74K | 67.08K | 115.68K | 134.76K | 136.46K | 116.17K | 23.03K | 34.22K | 30.23K | — | — | — | — | — | — | — | — | — | — |
| BIT Capital GmbH | 427.00K | 266.00K | 134.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 271.05K | — | — | — | — | — | 175.89K | 122.14K | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 250.90K | 485.09K | 145.16K | 240.54K | 239.16K | 345.63K | 221.96K | 174.51K | 83.47K | 2.15K | 2.15K | 2.15K | 2.15K | 2.15K | — | 1 | 1.13K | 2.03K | 1.75K | 8.77K |
| Nuveen, LLC | 224.04K | 209.10K | 76.29K | 76.29K | 76.29K | 76.29K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 158.92K | 166.93K | 144.15K | 132.90K | 145.87K | 134.32K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Russell Investments Group, Ltd. | 127.93K | 40.92K | 5.29K | 10.78K | 4.85K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| LPL Financial LLC | 122.06K | 111.69K | 74.96K | 17.46K | 13.65K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold ELDN?
As of 2026-Q2, 169 institutional funds reported holding ELDN (ELEDON PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $190.54M.
How many shares of ELDN do institutions own?
13F filers reported 48.59M shares of ELDN, worth $190.54M in aggregate at the end of 2026-Q2.
Is institutional ownership of ELDN rising or falling?
Share counts moved +9.2% versus the prior quarter — accumulation.
Who are the top institutional holders of ELDN?
The largest 13F holders are BVF INC/IL, BlackRock Inc, Defilade Capital Management, L.P., Goldman Sachs Group, RA CAPITAL MANAGEMENT, L.P.; the top 25 are ranked at the top of this page.
Who are the major shareholders of ELEDON PHARMACEUTICALS INC?
The major shareholders of ELEDON PHARMACEUTICALS INC (ELDN) by reported 13F value are BVF INC/IL, BlackRock Inc, Defilade Capital Management, L.P., Goldman Sachs Group, RA CAPITAL MANAGEMENT, L.P., among 258 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.